Ástralía - enska - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - sea snake antivenom, quantity: 1000 u - injection, concentrated - excipient ingredients: phenol; sodium chloride; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a sea snake.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - taipan antivenom, quantity: 12000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a taipan.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - death adder antivenom, quantity: 6000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a death adder.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - tiger snake antivenom, quantity: 3000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite of a tiger, copperhead or black snake.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - black snake antivenom, quantity: 18000 u - injection, concentrated - excipient ingredients: sodium chloride; phenol; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a king brown or mulga snake. although the antivenom is effective in the management of patients who are bitten by other members of the genus pseudechis, including the red-bellied or common black snake, tiger snake antivenom is the preferred treatment.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 250 iu; anti-d rho immunoglobulin, quantity: 10 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - rh(d) immunoglobulin is indicated for the prevention of rh sensitisation in rh(d)negative females at or below child bearing age.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - rabies virus, quantity: 2.5 iu - injection, powder for - excipient ingredients: monopotassium glutamate; trometamol; sodium chloride; disodium edetate; polygeline; sucrose - active immunisation against rabies virus, including a) pre-exposure immunisation b) post-exposure treatment following exposure to rabies virus.

Singapúr - enska - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - rabies immune globulin (human) - injection - 150 iu/ml - rabies immune globulin (human) 150 iu/ml

Armenía - enska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

serum institute of india pvt ltd. - purified rabies antigen - powder lyophilized for solution for injection and solvent - 2,5iu/ml

Singapúr - enska - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - live attenuated measles virus (schwarz strain); live attenuated mumps virus (rit4385 strain); live attenuated rubella virus (wistar ra 27/3 strain); live attenuated varicella virus (oka strain) - injection, powder, lyophilized, for solution - ≥ 10 3.0 ccid50 /dose - live attenuated measles virus (schwarz strain) ≥ 10³ ccid50/dose; live attenuated mumps virus (rit4385 strain) ≥ 10⁴·⁴ ccid50/dose; live attenuated rubella virus (wistar ra 27/3 strain) ≥ 10³ ccid50/dose; live attenuated varicella virus (oka strain) ≥ 10³·³ pfu/dose